Structures by: Low J. N.
Total: 892
(<i>E</i>)-2-Oxo-<i>N</i>'-(3,4,5-trimethoxybenzylidene)-2<i>H</i>-chromene-3-carbohydrazide dimethyl sulfoxide hemisolvate
C20H18N2O6,0.5C2H6OS
Acta Crystallographica Section E (2019) 75, 10 1403-1410
a=33.0258(7)Å b=5.44120(10)Å c=22.4342(4)Å
α=90° β=107.203(2)° γ=90°
<i>N</i>-(6-Hydroxyhexyl)-3,4,5-trimethoxybenzamide
C16H25NO5
Acta Crystallographica Section E (2016) 72, 5 675-682
a=22.3351(18)Å b=5.0467(4)Å c=14.2265(10)Å
α=90° β=99.956(7)° γ=90°
<i>N</i>-(6,6-Diethoxyhexyl)-3,4,5-trimethoxybenzamide
C20H33NO6
Acta Crystallographica Section E (2016) 72, 5 675-682
a=24.6345(18)Å b=8.4646(5)Å c=10.0598(7)Å
α=90° β=100.851(2)° γ=90°
<i>N</i>-(6-Anilinohexyl)-3,4,5-trimethoxybenzamide
C22H30N2O4
Acta Crystallographica Section E (2016) 72, 5 675-682
a=11.5626(8)Å b=19.5328(9)Å c=9.5488(7)Å
α=90° β=109.369(8)° γ=90°
C20H14N2O3
C20H14N2O3
Acta Crystallographica Section E (2016) 72, 8 1121-1125
a=7.799(3)Å b=7.014(3)Å c=27.640(18)Å
α=90° β=90.18(6)° γ=90°
6-Methyl-<i>N</i>-(3-methylphenyl)-2-oxo-2<i>H</i>-chromene-3-carboxamide
C18H15NO3
Acta Crystallographica Section E (2016) 72, 7 926-932
a=7.2117(3)Å b=8.0491(3)Å c=23.6242(9)Å
α=90° β=94.388(4)° γ=90°
6-Methoxy-<i>N</i>-(3-methoxyphenyl)-2-oxo-2<i>H</i>-chromene-3-carboxamide
C18H15NO5
Acta Crystallographica Section E (2016) 72, 7 926-932
a=6.7722(5)Å b=8.3098(7)Å c=14.4202(13)Å
α=91.874(7)° β=100.009(7)° γ=113.042(7)°
6-Methyl-<i>N</i>-(3-methoxyphenyl)-2-oxo-2<i>H</i>-chromene-3-carboxamide
C18H15NO4
Acta Crystallographica Section E (2016) 72, 7 926-932
a=7.1028(4)Å b=10.1367(4)Å c=10.8171(5)Å
α=75.827(4)° β=88.318(4)° γ=71.271(4)°
7-Hydroxy-3-(2-methoxyphenyl)-2-trifluoromethyl-4<i>H</i>-chromen-4-one
C17H11F3O4
Acta Crystallographica Section E (2017) 73, 8 1130-1134
a=7.9147(5)Å b=16.2171(11)Å c=22.5254(16)Å
α=90° β=90° γ=90°
<i>N</i>-(4-Fluorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C16H10FNO3
Acta Crystallographica Section E (2015) 71, 1 88-93
a=6.6213(5)Å b=7.0517(5)Å c=14.0864(10)Å
α=101.957(7)° β=90.047(6)° γ=106.657(7)°
<i>N</i>-(4-Bromophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C16H10BrNO3
Acta Crystallographica Section E (2015) 71, 1 88-93
a=6.6505(5)Å b=9.3580(7)Å c=11.0060(8)Å
α=100.280(6)° β=90.461(6)° γ=100.884(6)°
<i>N</i>-(4-Chlorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C16H10ClNO3
Acta Crystallographica Section E (2015) 71, 1 88-93
a=6.6325(12)Å b=7.0577(12)Å c=14.671(3)Å
α=103.536(7)° β=89.714(6)° γ=105.589(7)°
<i>N</i>-(4-Iodophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C16H10INO3
Acta Crystallographica Section E (2015) 71, 1 88-93
a=6.6750(5)Å b=9.4166(7)Å c=11.2673(8)Å
α=100.974(6)° β=90.769(6)° γ=100.062(6)°
Ethyl 6-(4-methylphenyl)-4-oxo-4<i>H</i>-chromene-2-carboxylate
C19H16O4
Acta Crystallographica Section E (2016) 72, 1 8-13
a=14.7129(11)Å b=18.9613(13)Å c=11.3031(6)Å
α=90° β=111.632(7)° γ=90°
Ethyl 6-(4-fluorophenyl)-4-oxo-4<i>H</i>-chromene-2-carboxylate
C18H13FO4
Acta Crystallographica Section E (2016) 72, 1 8-13
a=3.8521(2)Å b=20.6970(15)Å c=17.5478(11)Å
α=90° β=91.5460(10)° γ=90°
<i>N</i>-(5-Methylthiazol-2-yl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C14H10N2O3S
Acta Crystallographica Section E (2017) 73, 8 1154-1161
a=4.8722(4)Å b=12.0436(10)Å c=21.9803(16)Å
α=90° β=96.353(8)° γ=90°
C14H10N2O3S
C14H10N2O3S
Acta Crystallographica Section E (2017) 73, 8 1154-1161
a=7.4646(5)Å b=30.626(2)Å c=11.0869(8)Å
α=90° β=93.232(2)° γ=90°
2-[(9-Acetyl-9<i>H</i>-purin-6-yl)sulfanyl]-1-(3-methoxyphenyl)ethan-1-one
C16H14N4O3S
Acta Crystallographica Section E (2016) 72, 3 307-313
a=7.6343(5)Å b=26.2356(18)Å c=8.1332(5)Å
α=90° β=112.725(2)° γ=90°
2-[(9-Acetyl-9<i>H</i>-purin-6-yl)sulfanyl]-1-(4-methoxyphenyl)ethan-1-one
C16H14N4O3S
Acta Crystallographica Section E (2016) 72, 3 307-313
a=5.9920(3)Å b=9.9795(5)Å c=24.9907(13)Å
α=90° β=95.977(5)° γ=90°
2-[(9-Acetyl-9<i>H</i>-purin-6-yl)sulfanyl]-1-(4-chlorophenyl)ethan-1-one
C15H11ClN4O2S
Acta Crystallographica Section E (2016) 72, 3 307-313
a=5.9900(4)Å b=9.9169(7)Å c=24.3238(17)Å
α=90° β=96.072(2)° γ=90°
2-[(9-Acetyl-9<i>H</i>-purin-6-yl)sulfanyl]-1-(4-bromophenyl)ethan-1-one
C15H11BrN4O2S
Acta Crystallographica Section E (2016) 72, 3 307-313
a=6.0705(4)Å b=10.0668(7)Å c=24.3492(17)Å
α=90° β=96.580(2)° γ=90°
1-(3-Methoxyphenyl)-2-[(9<i>H</i>-purin-6-yl)sulfanyl]ethan-1-one
C14H12N4O2S
Acta Crystallographica Section E (2016) 72, 3 307-313
a=7.6683(5)Å b=21.8004(15)Å c=8.4131(5)Å
α=90° β=107.507(2)° γ=90°
6-(2-Hydroxybenzoyl)-5<i>H</i>-thiazolo[3,2-<i>a</i>]pyrimidin-5-one
C13H8N2O3S
Acta Crystallographica Section E (2015) 71, 7 766-771
a=7.5563(5)Å b=15.3187(11)Å c=10.1229(7)Å
α=90° β=99.49(2)° γ=90°
6-(2-Hydroxybenzoyl)-2-methyl-5<i>H</i>-thiazolo[3,2-<i>a</i>]pyrimidin-5-one
C14H10N2O3S
Acta Crystallographica Section E (2015) 71, 7 766-771
a=3.931(2)Å b=10.459(6)Å c=14.657(8)Å
α=90° β=94.201(14)° γ=90°
<i>N</i>-Methyl-4-oxo-<i>N</i>-phenyl-4<i>H</i>-chromene-3-carboxamide
C17H13NO3
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 11 1270-1277
a=6.716(4)Å b=6.809(4)Å c=29.425(17)Å
α=90.00° β=94.784(7)° γ=90.00°
3-(Pyrrolidine-1-carbonyl)-4<i>H</i>-chromen-4-one
C14H13NO3
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 11 1270-1277
a=7.430(3)Å b=11.963(6)Å c=12.648(6)Å
α=90° β=90° γ=90°
2-(Pyrrolidine-1-carbonyl)-4<i>H</i>-chromen-4-one
C14H13NO3
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 11 1270-1277
a=15.337(6)Å b=21.940(8)Å c=6.808(3)Å
α=90° β=90° γ=90°
2-Methoxycarbonyl-4-nitroacetanilide
C10H10N2O5
Acta Crystallographica Section E (2004) 60, 5 o852-o854
a=16.4482(14)Å b=19.9095(17)Å c=6.7549(6)Å
α=90.00° β=90.00° γ=90.00°
4-Bromo-β-(2-oxoquinolin-4-yloxy)cinnamonitrile
C18H11BrN2O2
Acta Crystallographica Section E (2006) 62, 7 o3056-o3058
a=8.9860(2)Å b=12.4111(3)Å c=13.6138(3)Å
α=90.00° β=92.006(2)° γ=90.00°
Methyl 2-benzyl-1-benzyloxy-6a-methyl-1,2,3,3a,4,6a-hexahydro- 1-azapentalene-3a-carboxylate
C24H27NO3
Acta Crystallographica Section E (2006) 62, 1 o165-o167
a=8.8410(17)Å b=20.584(4)Å c=22.344(2)Å
α=90.00° β=90.00° γ=90.00°
Glyoxal 3-nitrophenylhydrazone
C8H7N3O3
Acta Crystallographica Section E (2006) 62, 5 o1816-o1818
a=7.4737(4)Å b=19.7711(13)Å c=6.0262(4)Å
α=90.00° β=107.080(4)° γ=90.00°
2-Nitrophenylacetic acid
C8H7NO4
Acta Crystallographica Section E (2006) 62, 5 o1915-o1917
a=9.3182(3)Å b=9.4466(2)Å c=9.9733(3)Å
α=90.00° β=114.7990(17)° γ=90.00°
Glyoxal 2-nitrophenylhydrazone
C8H7N3O3
Acta Crystallographica Section E (2006) 62, 6 o2204-o2206
a=18.670(4)Å b=3.7723(4)Å c=23.896(5)Å
α=90.00° β=96.429(6)° γ=90.00°
1-(4-Methylphenylsulfonyl)-1H-1,2,3-benzotriazole
C13H11N3O2S
Acta Crystallographica Section E (2005) 61, 9 o2795-o2797
a=7.4211(3)Å b=9.2176(3)Å c=9.7823(3)Å
α=98.614(3)° β=104.249(2)° γ=102.684(3)°
2-(Benzotriazol-1-ylmethyl)-1-phenyl-3-pyrazolidinone
C16H15N5O
Acta Crystallographica Section E (2003) 59, 1 o66-o69
a=6.4009(2)Å b=8.3596(3)Å c=13.2794(5)Å
α=92.7780(10)° β=94.3820(10)° γ=95.039(3)°
3-tert-butyl-5-[(4-methoxybenzylidene)amino]-1-phenylpyrazole
C21H23N3O
Acta Crystallographica Section E (2003) 59, 2 o250-o252
a=10.0744(3)Å b=6.2583(2)Å c=28.9244(9)Å
α=90.00° β=101.0410(13)° γ=90.00°
1-(4-bromophenyl)-3-[2-(2-hydroxyethyl)amino-5-nitroanilino]-1-propanone
C17H18BrN3O4,C3H7NO
Acta Crystallographica Section E (2003) 59, 3 o296-o298
a=10.5267(2)Å b=10.7688(3)Å c=10.9397(3)Å
α=77.646(2)° β=72.743(2)° γ=62.7565(12)°
6(R)-Acetoxymethyl-5(S)-acetyl-2(S)-(benzotriazol-1-yl)-5,6-dihydro-2H-pyran
C16H17N3O5
Acta Crystallographica Section E (2003) 59, 3 o334-o336
a=5.5167(3)Å b=17.7388(11)Å c=8.2217(5)Å
α=90.00° β=94.139(3)° γ=90.00°
1-(Benzotriazol-1-ylmethyl)-5-(4-dimethylaminophenyl)-3- phenyl-4,5-dihydro-1H-pyrazole
C24H24N6
Acta Crystallographica Section E (2003) 59, 4 o517-o518
a=10.8485(2)Å b=14.4584(4)Å c=14.0433(4)Å
α=90.00° β=106.8400(10)° γ=90.00°
5-(Benzo[1,3]dioxol-5-yl)-7-(4-chloro-phenyl)-3-methyl-1-phenyl-1,6,7,8- tetrahydropyrazolo[3,4-b][1,4]diazepine
C26H21ClN4O2
Acta Crystallographica Section E (2003) 59, 1 o18-o20
a=11.3422(2)Å b=15.6889(3)Å c=24.1716(5)Å
α=90.00° β=92.4370(10)° γ=90.00°
5-(1,3-benzodioxol-5-yl)-3-methyl-1,7-diphenyl-1,6,7,8-tetrahydropyrazolo [3,4-b][1,4]diazepine
C26H22N4O2
Acta Crystallographica Section E (2003) 59, 5 o614-o615
a=10.2608(8)Å b=10.9910(6)Å c=11.2485(8)Å
α=63.656(4)° β=63.573(3)° γ=77.080(5)°
1-chloroacetyl-2,4-diphenyl-2,3-dihydro-1H-1,5-benzodiazepine
C23H19ClN2O
Acta Crystallographica Section E (2003) 59, 5 o603-o605
a=31.7081(8)Å b=7.8174(2)Å c=15.4208(5)Å
α=90.00° β=104.3440(10)° γ=90.00°
Bis-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-3,4,5-trimethoxyphenylmethane
C30H32N6O3
Acta Crystallographica Section E (2004) 60, 6 o1034-o1037
a=9.7540(2)Å b=33.4646(7)Å c=8.90100(10)Å
α=90.00° β=103.6020(9)° γ=90.00°
Rac-5-Acetyl-6-(4-nitrophenyl)-6,7-dihydro-5H-1,3-dioxolo[4,5-g]quinoline-8-one
C18H14N2O6
Acta Crystallographica Section E (2004) 60, 6 o1057-o1059
a=6.5253(2)Å b=21.4286(5)Å c=10.8198(9)Å
α=90.00° β=90.00° γ=90.00°
11-(4-bromophenyl)-10-methyl-8-phenyl-6,8-dihydro-5H- benzo[f]pyrazolo[3,4-b]quinoline
C27H20BrN3
Acta Crystallographica Section E (2005) 61, 6 o1702-o1703
a=7.0237(3)Å b=12.8964(7)Å c=13.3517(7)Å
α=106.630(3)° β=101.423(3)° γ=102.274(3)°
(1R,2R)-N,N'-bis(4-nitrophenylmethylene)cyclohexane-1,2-diamine
C20H20N4O4
Acta Crystallographica Section E (2005) 61, 6 o1699-o1701
a=52.275(3)Å b=5.3605(2)Å c=14.0209(8)Å
α=90.00° β=104.952(2)° γ=90.00°
3-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)-1,5-di-2-thienylpentane-1,5-dione
C23H19ClN2O2S2
Acta Crystallographica Section E (2005) 61, 6 o1892-o1894
a=14.6729(5)Å b=17.8962(6)Å c=16.2619(3)Å
α=90.00° β=90.00° γ=90.00°
Α-Tris(2,4-pentanedionato-κ^2^O,O)vanadium(III)
C15H21O6V
Acta Crystallographica Section E (2005) 61, 7 m1326-m1328
a=13.3920(7)Å b=16.4043(6)Å c=15.1901(10)Å
α=90.00° β=90.00° γ=90.00°
3,5-Dimethyl-1,7-diphenyl-1,7-dihydrodipyrazolo[3,4-b,4',3'-e]pyridine
C21H17N5
Acta Crystallographica Section E (2006) 62, 5 o1676-o1678
a=21.2976(4)Å b=10.9267(3)Å c=7.4201(2)Å
α=90.00° β=98.108(2)° γ=90.00°
6-(4-fluorophenyl)-5,6-dihydrobenzimidazo[1,2-c]quinazoline
C20H14FN3
Acta Crystallographica, Section E: Structure Reports Online (2003) 59, 11 o1801-o1803
a=22.3211(8)Å b=22.3211(8)Å c=17.2220(9)Å
α=90.00° β=90.00° γ=120.00°
3,5-Dimethyl-1,7-diphenyl-4-(2-pyridinyl)-1H,7H-pyrazolo[3,4-b:4',3'-e]pyridine
C26H20N6
Acta Crystallographica Section E (2003) 59, 9 o1327-o1329
a=8.4576(2)Å b=10.6599(3)Å c=12.3642(4)Å
α=106.9170(14)° β=98.6240(16)° γ=100.803(2)°
3,5-Dimethyl-1,4,7-triphenyl-1H,7H-pyrazolo[3,4-b:4',3'-e]pyridine
C27H21N5
Acta Crystallographica Section E (2003) 59, 9 o1330-o1331
a=8.5006(2)Å b=10.5829(3)Å c=12.4093(3)Å
α=106.0775(12)° β=97.6152(15)° γ=100.6751(10)°
3,7,7-trimethyl-1-phenyl-1,6,7,8-tetrahydro-5H-pyrazolo[3,4-b]quinolin-5-one
C19H19N3O
Acta Crystallographica Section E (2003) 59, 11 o1804-o1806
a=10.6825(4)Å b=11.9254(4)Å c=13.1219(6)Å
α=111.2105(17)° β=90.5164(18)° γ=96.533(2)°
1-(p-Chlorophenyl)-3,4-dimethyl-5,6,7,8-tetrahydropyrazolo[3,4-b]quinoline
C18H18ClN3
Acta Crystallographica Section E (2003) 59, 11 o1657-o1658
a=10.2097(6)Å b=7.5773(3)Å c=20.6921(12)Å
α=90.00° β=110.203(3)° γ=90.00°
4-(4-bromophenyl)-3,7,7-trimethyl-4,7,8,9-tetrahydro-2H-pyrazolo[3,4-b] quinolin-5(6H)-one
C19H20BrN3O
Acta Crystallographica Section E (2001) 57, 2 o151-o153
a=8.6673(2)Å b=14.6092(3)Å c=14.4783(5)Å
α=90.00° β=107.2870(10)° γ=90.00°
3,7,7-Trimethyl-4-(β-naphthyl)-4,7,8,9-tetrahydro-2H-pyrazolo[3,4-b]- quinolin-5(6H)-one
C23H23N3O
Acta Crystallographica Section E (2001) 57, 2 o160-o162
a=9.1222(18)Å b=15.281(3)Å c=14.346(3)Å
α=90.00° β=106.13(3)° γ=90.00°
5-(1,3-Benzothiazol-2-yliminomethyl)-2,2-dimethyl-1,3-dioxane-4,6-dione
C14H12N2O4S
Acta Crystallographica Section E (2001) 57, 2 o180-o181
a=6.3459(13)Å b=19.235(4)Å c=11.144(2)Å
α=90.00° β=103.07(3)° γ=90.00°
6-(2-Hydroxybenzoyl)-2-(4-nitrophenyl)pyrazolo[1,5-a]pyrimidine
C19H12N4O4
Acta Crystallographica Section E (2001) 57, 2 o182-o184
a=5.5421(2)Å b=11.5858(5)Å c=23.8057(13)Å
α=90.00° β=90.00° γ=90.00°
5,5-Dimethyl-3-[(5-phenyl-1H-pyrazol-3-yl)amino]cyclohex-2-en-1-one
C17H19N3O
Acta Crystallographica Section E (2001) 57, 2 o185-o186
a=19.0427(2)Å b=9.6024(4)Å c=16.6135(7)Å
α=90.00° β=90.00° γ=90.00°
6-(2-hydroxybenzoyl)-2-phenylpyrazolo[1,5-a]pyrimidine
C19H13N3O2
Acta Crystallographica Section E (2001) 57, 2 o187-o188
a=5.6606(2)Å b=11.7048(5)Å c=21.6815(10)Å
α=90.00° β=94.7970(15)° γ=90.00°
Tetradecyl-triphenylstannane
C32H44Sn
Acta Crystallographica Section E (2001) 57, 3 m95-m96
a=7.5468(15)Å b=9.874(2)Å c=20.378(4)Å
α=95.20(3)° β=91.64(3)° γ=110.15(3)°
3,7,7-Trimethyl-4-(4-methoxyphenyl)-4,7,8,9-tetrahydro-2H-pyrazolo[3,4-b]- quinolin-5(6H)-one (4).
C20H23N3O2
Acta Crystallographica Section E (2001) 57, 2 o154-o156
a=8.5820(3)Å b=14.7031(5)Å c=14.5369(8)Å
α=90.00° β=106.0610(15)° γ=90.00°
3,7,7-Trimethyl-4-phenyl-4,7,8,9-tetrahydro-2H-pyrazolo[3,4-b]quinolin-5- (6H)-one
C19H21N3O
Acta Crystallographica Section E (2001) 57, 2 o157-o159
a=10.0870(5)Å b=14.1978(5)Å c=11.1928(8)Å
α=90.00° β=96.0340(14)° γ=90.00°
6-(1H-1,2,3-Benzotriazol-1-yl)-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinoline
C17H16N4
Acta Crystallographica Section E (2001) 57, 2 o178-o179
a=10.7112(3)Å b=10.8297(3)Å c=23.6321(5)Å
α=90.00° β=90.00° γ=90.00°
5-Amino-4-(benzotriazol-1-ylmethyl)-1-phenyl-3-tert-butylpyrazole
C20H22N6
Acta Crystallographica Section E (2002) 58, 1 o53-o54
a=13.465(3)Å b=15.135(3)Å c=9.1558(18)Å
α=90.00° β=108.86(3)° γ=90.00°
5-[(6-Chloro-[1,3]benzothiazol-2-ylamino)-methylene]-2,2-dimethyl- [1,3]dioxane-4,6-dione
C14H11ClN2O4S
Acta Crystallographica Section E (2002) 58, 1 o57-o58
a=5.3389(4)Å b=28.583(2)Å c=9.8618(8)Å
α=90.00° β=109.178(4)° γ=90.00°
1-(2-Methyl-2,3-dihydro-indol-1-ylmethyl)-1H-benzotriazole
C16H16N4
Acta Crystallographica Section E (2002) 58, 1 o55-o56
a=7.5660(3)Å b=17.7842(8)Å c=10.2284(4)Å
α=90.00° β=104.689(3)° γ=90.00°
N-(6-amino-3,4-dihydro-3-methyl-5-nitroso-4-oxopyrimidin-2-yl)glycylglycinate
C9H12N6O5
Acta Crystallographica Section E (2002) 58, 8 o942-o945
a=7.4727(6)Å b=8.2356(4)Å c=9.6678(8)Å
α=81.208(5)° β=88.722(3)° γ=76.169(4)°
3-(Benzotriazol-1-yl)-p-nitropropiophenone
C15H12N4O3
Acta Crystallographica Section E (2002) 58, 7 o769-o771
a=5.9554(2)Å b=6.9671(3)Å c=31.8248(13)Å
α=90.00° β=96.8560(17)° γ=90.00°
5-(2-Acetyloxyphenyl)-3-phenyl-1,2,4-oxadiazole
C16H12N2O3
Acta Crystallographica Section E (2003) 59, 11 o1729-o1730
a=14.5489(8)Å b=5.4293(3)Å c=17.2806(13)Å
α=90.00° β=105.955(2)° γ=90.00°
Fluoren-9-one 4-toluenesulfonylhydrazone
C20H16N2O2S
Acta Crystallographica Section E (2004) 60, 4 o520-o522
a=7.7487(2)Å b=10.4290(3)Å c=11.2007(3)Å
α=71.8482(13)° β=76.9553(17)° γ=75.3167(17)°
C56H58Cl2O4Sn4,2C7H8
C56H58Cl2O4Sn4,2C7H8
Acta Crystallographica Section E (2004) 60, 4 m489-m491
a=10.0738(2)Å b=15.5680(3)Å c=20.3943(3)Å
α=90.00° β=96.6730(10)° γ=90.00°
(E)-{[2-(phenyldiazenyl)phenyl]ethylideneaminooxy}acetic acid
C16H15N3O3
Acta Crystallographica Section E (2004) 60, 9 o1560-o1562
a=16.927(2)Å b=4.5244(5)Å c=19.673(2)Å
α=90.00° β=105.828(5)° γ=90.00°
N,N'-bis(3-nitrobenzylidene)octane-1,8-diamine
C22H26N4O4
Acta Crystallographica Section E (2005) 61, 11 o3551-o3553
a=8.1297(5)Å b=19.2452(15)Å c=7.4113(4)Å
α=90.00° β=115.321(4)° γ=90.00°
(E)-3-(4-Chlorophenyl)-2-(2-thienyl)acrylonitrile
C13H8ClNS
Acta Crystallographica Section E (2005) 61, 11 o3639-o3641
a=3.8142(2)Å b=23.6852(8)Å c=12.5319(5)Å
α=90.00° β=97.2160(16)° γ=90.00°
Elaidic acid
C18H34O2
Acta Crystallographica Section E (2005) 61, 11 o3730-o3732
a=98.48(2)Å b=4.9381(3)Å c=7.1826(8)Å
α=90° β=92.570(12)° γ=90°
(E)-3-(4-nitrophenylaminocarbonyl)propen-2-oic acid
C10H8N2O5
Acta Crystallographica Section E (2005) 61, 11 o3849-o3851
a=9.6052(7)Å b=12.8416(10)Å c=9.0921(7)Å
α=90.00° β=114.388(2)° γ=90.00°
3-Methyl-4-(4-nitrophenyl)-1-phenyl-1,7-dihydro-6H- pyrazolo[3,4-b]thiazolo[5,4-e]pyridine-6- thione--dimethylformamide (1/1)
C20H13N5O2S2,C3H7NO
Acta Crystallographica Section E (2005) 61, 12 o3998-o4000
a=9.3023(2)Å b=25.5447(7)Å c=10.3794(2)Å
α=90.00° β=113.7660(13)° γ=90.00°
4-N-Acetylamino-5-[N-acetyl-N-(tetra-O-acetyl-β-D- glucopyranosyl)amino]-1,3-dimethyluracil
C24H32N4O13
Acta Crystallographica Section E (2006) 62, 3 o969-o971
a=8.84900(10)Å b=17.8429(2)Å c=18.3058(2)Å
α=90.00° β=103.7830(8)° γ=90.00°
(2,2'-Bipyridyl)bis(pentane-2,4-dionato)vanadium(III) perchlorate dichloromethane solvate
C20H22N2O4V,ClO4,CH2Cl2
Acta Crystallographica Section E (2006) 62, 3 m529-m531
a=15.0676(5)Å b=12.5534(3)Å c=14.5533(5)Å
α=90.00° β=111.4860(13)° γ=90.00°
1-Benzyl-2-[(2RS,3SR,6SR)-3-methyl-4-oxo-2,6-diphenylpiperidin-1-ylcarbonyl]- 2-phenylethenyl phenylacetate
C42H37NO4
Acta Crystallographica Section E (2006) 62, 4 o1443-o1445
a=9.3027(3)Å b=12.1333(5)Å c=14.5927(6)Å
α=88.7510(17)° β=78.574(3)° γ=85.653(2)°
(E,E)-1,4-Bis(2-iodophenyl)-2,3-diaza-1,3-butadiene
C14H10I2N2
Acta Crystallographica Section E (2006) 62, 4 o1565-o1566
a=13.2667(4)Å b=4.1070(2)Å c=13.8207(4)Å
α=90.00° β=110.3140(15)° γ=90.00°
(2RS,3SR,6SR)-3-ethyl-2,6-diphenyl-1-phenylacetyl-4-piperidone
C27H27NO2
Acta Crystallographica Section E (2006) 62, 4 o1452-o1454
a=19.355(6)Å b=22.944(8)Å c=9.959(3)Å
α=90.00° β=97.905(6)° γ=90.00°
(E,E)-1-(3-Iodophenyl)-4-(3-nitrophenyl)-2,3-diazabuta-1,3-diene
C14H10I0.82N3.18O2.34
Acta Crystallographica Section E (2006) 62, 4 o1399-o1401
a=3.8044(2)Å b=15.0015(11)Å c=11.6159(8)Å
α=90.00° β=90.658(4)° γ=90.00°
Acetone 3-nitrophenylhydrazone
C9H11N3O2
Acta Crystallographica Section E (2006) 62, 7 o2838-o2840
a=22.7837(15)Å b=3.8307(2)Å c=21.7292(13)Å
α=90.00° β=100.129(3)° γ=90.00°
N-(3,5-Dinitrobenzoyl)-N'-phenylhydrazine
C13H10N4O5
Acta Crystallographica Section E (2006) 62, 7 o2589-o2591
a=7.5696(3)Å b=22.176(2)Å c=8.4099(4)Å
α=90.00° β=110.802(3)° γ=90.00°
Acetone (2,6-dichlorobenzoyl)hydrazone
C10H10Cl2N2O
Acta Crystallographica Section E (2006) 62, 7 o2841-o2843
a=7.4980(3)Å b=8.1320(2)Å c=9.7759(3)Å
α=71.609(2)° β=80.822(2)° γ=89.033(2)°
2-Ethyl-2-(hydroxymethyl)-1,3-propanediol
C6H14O3
Acta Crystallographica Section E (2001) 57, 11 o1081-o1083
a=8.3806(2)Å b=9.5768(3)Å c=9.1466(3)Å
α=90.00° β=99.4790(13)° γ=90.00°
11-Chloro-5H-6,7-dihydrobenzothiazolo[2,3-b]benzo[h]quinazoline
C18H13Cl1N2S1
Acta Crystallographica Section E (2001) 57, 10 o937-o938
a=7.2637(3)Å b=14.4294(5)Å c=15.1081(5)Å
α=70.368(3)° β=78.550(2)° γ=89.0800(14)°
2-Nitrobenzaldehyde 2-iodobenzoylhydrazone
C14H10IN3O3
Acta Crystallographica Section E (2005) 61, 8 o2438-o2440
a=21.6122(8)Å b=5.0393(2)Å c=12.7868(5)Å
α=90.00° β=90.00° γ=90.00°
3-tert-butyl-4-(4-nitrophenyl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine
C22H20N4O2
Acta Crystallographica Section E (2005) 61, 8 o2625-o2627
a=9.5877(5)Å b=9.8541(5)Å c=11.7050(4)Å
α=105.982(2)° β=103.570(2)° γ=108.433(2)°
Dieuropium trisulfate octahydrate
Eu2H16O20S3
Acta Crystallographica Section E (2004) 60, 11 i142-i144
a=13.5029(3)Å b=6.76010(10)Å c=18.2628(3)Å
α=90.00° β=102.2610(13)° γ=90.00°
5-Chloro-2-nitrobenzaldehyde isonicotinoylhydrazone
C13H9ClN4O3
Acta Crystallographica Section E (2006) 62, 8 o3361-o3363
a=8.0597(2)Å b=10.4797(4)Å c=15.4798(6)Å
α=90.00° β=97.383(2)° γ=90.00°
6-(2-Hydroxybenzoyl)-2-(4-methylphenyl)-5-methyl-7- phenylpyrazolo[1,5-a]pyrimidine
C27H21N3O2
Acta Crystallographica Section E (2006) 62, 8 o3195-o3197
a=38.7649(11)Å b=6.7864(2)Å c=16.7002(5)Å
α=90.00° β=108.599(2)° γ=90.00°
4-amino-6-(2,2-diethoxyethoxy)-2-(methylsulfanyl)pyrimidine
C11H19N3O3S
Acta Crystallographica Section E (2006) 62, 8 o3142-o3144
a=7.2280(8)Å b=9.6360(9)Å c=10.0850(10)Å
α=81.197(9)° β=82.390(7)° γ=78.817(8)°
5-(4-Bromophenyl)-3-phenyl-1-(3-phenylpropyl)-1H-pyrazole
C24H21BrN2
Acta Crystallographica Section E (2004) 60, 3 o324-o326
a=5.67550(10)Å b=25.5102(5)Å c=26.5536(5)Å
α=90.00° β=90.00° γ=90.00°
2-Phenylbenzaldehydeoxime
C13H11NO
Acta Crystallographica Section E (2004) 60, 3 o422-o424
a=14.3555(4)Å b=4.49690(10)Å c=31.4473(10)Å
α=90.00° β=90.00° γ=90.00°
Diethyl 2-(4-nitrophenyl)malonate
C13H15NO6
Acta Crystallographica Section E (2004) 60, 1 o60-o62
a=11.9275(6)Å b=13.8407(8)Å c=8.4595(3)Å
α=90.00° β=99.192(3)° γ=90.00°
3-tert-Butyl-1-(4-chlorophenyl)-7,7-dimethyl-5,6,7,8- tetrahydroimidazo[3,4-b]quinolin-5-one
C22H24ClN3O
Acta Crystallographica Section E (2005) 61, 1 o49-o51
a=8.6851(11)Å b=10.6167(9)Å c=12.4330(12)Å
α=106.724(8)° β=101.049(10)° γ=107.406(8)°
11-(4-chlorophenyl)-10-methyl-8-phenyl-6,8-dihydro-5H- benzo[f]pyrazolo[3,4-b]quinoline
C27H20ClN3
Acta Crystallographica Section E (2005) 61, 4 o1058-o1060
a=7.12700(10)Å b=12.6300(4)Å c=13.2847(4)Å
α=107.3380(13)° β=103.6230(17)° γ=101.4230(18)°